Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2005
03/09/2005CN1592752A Inhibitors of the E2F-1/cyclin interaction for cancer therapy
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592637A Medicinal compositions
03/09/2005CN1592636A Immunotherapeutic combinations for the treatment of tumors
03/09/2005CN1592635A Autologous growth factor cocktail composition, method of production and use
03/09/2005CN1592634A Non-neurotoxic plasminogen activating factors for treating stroke
03/09/2005CN1592633A T-cell epitodes in carboxypeptidase G2
03/09/2005CN1592632A Combined use of VII polypeptides and factor VIII polypeptides
03/09/2005CN1592631A Crystal modification of a cyclic depsipeptide having improved strength
03/09/2005CN1592630A Injection solution comprising an LHRH antagonist
03/09/2005CN1592629A L-methionine as a stabilizer for NESP/EPO in hsa-free formulations
03/09/2005CN1592607A Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
03/09/2005CN1592588A Necktie wearing unit
03/09/2005CN1592581A Methods and compositions for use in pet breeding
03/09/2005CN1590547A Encoding gene sequence of nereid kinase possessing embolus dissolving activity and its amino acid sequence
03/09/2005CN1590543A Thermostable Taq polymerase fragment
03/09/2005CN1590408A Preparation technology of globe fish peptide and its medical health care use
03/09/2005CN1590407A Multifunctional blood forming receptor agonist
03/09/2005CN1590404A Antigenic meningococcal peptides
03/09/2005CN1590403A Hexapeptide and its application
03/09/2005CN1589908A Tenascin-C nucleic acid ligands
03/09/2005CN1589905A Medical composition for treating desmosis and its use
03/09/2005CN1589904A Use of hemopoietic stem cell mobilizer in preparation of medicine for treating diabetes
03/09/2005CN1589903A Methods for amyloid removal using anti-amyloid antibodies
03/09/2005CN1589902A Application of anti-lymphotoxin-beta receptor antibodies in preparation of medical composition
03/09/2005CN1589900A Medical health protection use of globe fish glue
03/09/2005CN1589899A Application of recombination now type composite interferon in preventing and treating SARS
03/09/2005CN1589898A Application of human interferon alpha 2a in preparation of medicine for preventing and treating SARS
03/09/2005CN1589897A Biological immune preparation for treating dairy cattle clinical mamitis and its manufacturing method
03/09/2005CN1589896A Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication
03/09/2005CN1589895A Anti virus health care product extracted from sea weed and its preparation method
03/09/2005CN1192109C Anticoagulant fusion protein anchored to cell membrane
03/09/2005CN1192105C A variant of C6 beta-chemokine leukotactin-1(shLKn-1) with enhanced biological activity
03/09/2005CN1192101C Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192020C Antidiabetic agents
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/09/2005CN1191864C Hemoglobin-polysaccharide conjugates
03/09/2005CN1191863C Formulations for protection of PEG-alpha interferon conjugates
03/09/2005CN1191859C Docetaxel in combination with rhumab HER2 monoclone antibody for treatment of cancers
03/09/2005CN1191858C Method for inhibiting brain tnmor growth
03/09/2005CN1191857C potentiation of anti-CD38-immunotoxin cytotoxicity
03/09/2005CN1191856C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
03/09/2005CN1191855C Remedies for lymphocytic tumors
03/09/2005CN1191854C Model membrane systems
03/09/2005CN1191851C Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof
03/09/2005CN1191850C Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti -CD20 antibody
03/09/2005CN1191832C Neovascularization promoters
03/09/2005CN1191823C Cell for producing alginate capsules
03/09/2005CN1191760C Process for preparing nutritional supplement
03/09/2005CN1191754C Preserving hemoglobin blood substitute with transparent overwrap
03/08/2005US6864364 MinK-related genes, formation of potassium channels and association with cardiac arrhythmia
03/08/2005US6864363 Dipeptidylpeptidases and methods of use
03/08/2005US6864359 Structure-based screening techniques for drug discovery
03/08/2005US6864358 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
03/08/2005US6864356 Amino acid sequence of pyroglutamyl-leucinyl-lysinyl-cysteinyl-tyrosinyl-threoninyl-cysteinyl -lysinyl-gluta myl-prolinyl-methioninyl-threoninyl-serinyl-alaninyl-alaninyl-cysteine, in a peptide, is used as antitumor agent
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864250 N-acylated lipophilic amino acid derivatives
03/08/2005US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
03/08/2005US6864242 Mixtures of arginine, glutamine, proline and acyclic carboxy amines selected from leucine, isoleucine or valine, used as nutraceuticals for prophylaxis of metabolic disorders
03/08/2005US6864239 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
03/08/2005US6864238 Methods and compositions for destabilizing microtubules
03/08/2005US6864237 Preventing organ destruction and shut-down due to shock in a patient suffering from sepsis or at risk for sepsis
03/08/2005US6864236 Central nervous system disorders; muscular disorders; stabilization of a dystrophin complex
03/08/2005US6864235 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
03/08/2005US6864234 Somatostatin agonists
03/08/2005US6864233 Fungicidal echinocandin derivatives and their preparation
03/08/2005US6864232 Agent for treating visual cell function disorder
03/08/2005US6864231 Glycoprotein matrix compositions and methods related thereto
03/08/2005US6864230 Glutamine rich dietary composition
03/08/2005US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
03/08/2005US6864228 Use of bisphosphonates for the treatment of osteogenesis imperfecta
03/08/2005US6864227 Artery-and vein-specific proteins and uses therefor
03/08/2005US6864083 Expression vectors; use in identifying compound that modulates receptor activated calcium mobilization
03/08/2005US6864079 Human kinase and polynucleotides encoding the same
03/08/2005US6864078 14790, novel protein kinase molecule and uses therefor
03/08/2005US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders
03/08/2005US6864069 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
03/08/2005US6864068 Mutant plant
03/08/2005US6864067 Compositions and methods for regulating bacterial pathogenesis
03/08/2005US6864066 Epithelial protein lost in neoplasm (EPLIN)
03/08/2005US6864064 18891, a novel human lipase
03/08/2005US6864054 Polypeptides from CREB binding protein and related protein p300 for use in transcriptional regulation
03/08/2005US6864047 Culturing stromal cells with bone marrow, quantitative determining the concentration of interleukins by comparing to a standard curve; identifying a patient with a multiple myeloma- related plasmaproliferative disorder
03/08/2005US6863903 Pharmaceutical product comprising anti-secretory protein from egg yolk
03/08/2005US6863894 Mutant Salmonella; anticancer agents
03/08/2005US6863892 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer
03/08/2005US6863891 Oligopeptide lyophilisate, their preparation and use
03/08/2005US6863890 Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha
03/08/2005US6863889 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, immune, autoimmune, bone, nervous system, inflammatory and skin disorders
03/08/2005US6863888 Oncoprotein protein kinase
03/08/2005US6863887 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
03/08/2005US6863886 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
03/08/2005US6863885 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
03/08/2005US6863881 Compositions and methods of nematode control
03/08/2005US6863693 Phospholipid-coated implants
03/08/2005US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid
03/08/2005CA2262776C Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
03/08/2005CA2105230C Pharmaceutical or cosmetic composition containing peroxidase associated with an anti-oxygen singlet agent
03/08/2005CA2100212C Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
1 ... 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 ... 3163